Stada Acknowledges IPO Possibility Amid Latest Rumors
German Generics Giant Says Options Could Include Sale Or IPO
Amid rumors that Stada is sounding out investors for an IPO valued at around €1.5bn – following suggestions earlier this year that the company was being shopped around to potential buyers – the German generics giant has acknowledged to Generics Bulletin that options under review could include a sale or IPO.
